Enter your login e-mail to the account
Search
- Non-muscle invasive bladder cancer
MUDr. Ivona Wilšinská, doc. MUDr. Branislav Trebatický, PhD., prof. MUDr. Peter Bujdák, CSc.
(4/2022, Interdisciplinary consilium ) - How early diagnose urological malignancy in the office of a general practitioner
doc. MUDr. Jozef Marenčák, PhD.
(5/2014, Review articles )
- Complications of BCG intravesical therapy – BCGitis
MUDr. Petr Hušek, FEBU, MUDr. Jaroslav Pacovský, Ph.D., MUDr. Jiří Bureš, prof. MUDr. Miloš Broďák, Ph.D.
(5/2019, Communication from practice ) - Neoadjuvant chemotherapy for muscle-invasive bladder cancer
MUDr. Daniel Macík, MUDr. Michal Staník, Ph.D., doc. MUDr. Jan Doležel, PhD.
(4/2017, Review articles ) - Treatment of urothelial carcinoma bladder cancer
MUDr. Jana Katolická, Ph.D., MUDr. Lucia Tomková
(3/2023, Review articles ) - Current role of instillation chemotherapy and immunotherapy in treating non-invasive bladder cancer (Ta, T1, Tis)
MUDr. Pavel Sikora
(1/2016, Review articles ) - Systemic treatment for bladder cancer
doc. MUDr. Tomáš Büchler, Ph.D.
(3/2016, Review articles ) - Intravesical thermochemotherapy – indication, patient preparation and practical aspects of administration
doc. MUDr. Michal Fedorko, Ph.D., FEBU, MUDr. Alena Sorokač Kubolková, MUDr. Jakub Papirek, MUDr. Vítězslav Vít
(2/2023, Review articles ) - Immunotherapy in the bladder cancer treatment: long-term results
MUDr. Petr Hušek, FEBU, MUDr. Jaroslav Pacovský, Ph.D., MUDr. Miroslav Podhola, Ph.D., prof. MUDr. Miloš Broďák, Ph.D.
(4/2020, Communication from practice )
- Treatment of muscle-invasive bladder cancer
prof. MUDr. Ján Kliment, CSc.
(6/2016, Review articles ) - Systemic treatment of bladder cancer – neoadjuvant, adjuvant and palliative chemotherapy
MUDr. Branislav Bystrický, MUDr. Filip Kohútek, MUDr. Peter Kohútek, MUDr. Tomáš Sedláček
(3/2016, Review articles ) - Adjuvant therapy of bladder cancer
MUDr. Pavol Dubinský, PhD.
(5/2010, Review articles ) - Therapy and metaphylaxis of non muscle invasive bladder cancer (TaT1, CIS)
doc. MUDr. Milan Obšitník, CSc.
(5/2010, Review articles ) - SECONDARY MALIGNANCY AS A MANIFESTATION OF LATE TOXICITY OF CURATIVE TREATMENT FOR TESTICULAR CANCER
doc. MUDr. Elena Bolješíková, CSc., MUDr. Mária Rečková, MUDr. Mariánn Kakalejčík, MUDr. Juraj Beniak
(6/2008, Original articles ) - Therapy of muscle-invasive and metastatic bladder cancer from the point of view of the urologist
doc. MUDr. Milan Obšitník, CSc.
(6/2011, Review articles )